Andere Sprachen Silence Therapeutics plc

Aktien

A2QB4J

US82686Q1013

SLN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.05.2024			% 5 Tage	% 1. Jan.
23 ^USD	+0.26%		+8.44%	+32.41%

17.05.	Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Freitagshandel geringfügig höher	MT
16.05.	Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Donnerstagshandel niedriger	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	17.05.
Silence Therapeutics : Condensed consolidated income statement (unaudited) - Form 6-K	16.05.
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	16.05.
Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress	16.05.
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading	15.05.
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher	13.05.
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	09.05.
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference	30.04.
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors	29.04.
Silence Therapeutics plc Announces Retirement of Alistair Gray from Board of Directors, Effective May 1, 2024	29.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19.04.
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	16.04.
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	15.04.
Silence Therapeutics : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION - Form 6-K	15.04.
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	12.04.
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)	08.04.
Silence Therapeutics plc Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)	08.04.
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27.03.
European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading	18.03.
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading	15.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Silence Therapeutics plc

Aktien

A2QB4J

US82686Q1013

SLN

Andere Sprachen

Filter